
XPOVIO Continues To Disrupt The Oncology Market With Expanded Indications And Strong Market Performance Delveinsight
(MENAFN- PR Newswire) With global cancer incidence rising and a strong clinical pipeline exploring combination therapies, the XPOVIO addressable market is expanding. Despite competition from CAR-T and novel therapies, XPOVIO's oral administration and …